MALAT1 and breast cancer: Moreover, reports have established that a urinary exosome‐derived lncRNA panel (MALAT1, PCAT‐1, and SPRY4‐IT1) could be used as noninvasive diagnostic and prognostic biomarker of BC with considerable clinical value.